BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36843287)

  • 1. A novel de novo pathogenic variant in TBL1XR1 as a new proposed cause of Pierpont syndrome.
    Tamma PL; Streff H; Murali CN
    Am J Med Genet A; 2023 Jun; 191(6):1576-1580. PubMed ID: 36843287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBL1XR1 associated intellectual disability, a new missense variant with dysmorphic features plus autism: Expanding the phenotypic spectrum.
    Arroyo Carrera I; Fernández-Burriel M; Lapunzina P; Tenorio JA; García Navas VD; Márquez Isidro E
    Clin Genet; 2021 Jun; 99(6):812-817. PubMed ID: 33527360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific mutation in TBL1XR1 causes Pierpont syndrome.
    Heinen CA; Jongejan A; Watson PJ; Redeker B; Boelen A; Boudzovitch-Surovtseva O; Forzano F; Hordijk R; Kelley R; Olney AH; Pierpont ME; Schaefer GB; Stewart F; van Trotsenburg AS; Fliers E; Schwabe JW; Hennekam RC
    J Med Genet; 2016 May; 53(5):330-7. PubMed ID: 26769062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pierpont syndrome associated with the p.Tyr446Cys missense mutation in TBL1XR1.
    Slavotinek A; Pua H; Hodoglugil U; Abadie J; Shieh J; Van Ziffle J; Kvale M; Lee H; Kwok PY; Risch N; Sabbadini M
    Eur J Med Genet; 2017 Oct; 60(10):504-508. PubMed ID: 28687524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation.
    Lemattre C; Thevenon J; Duffourd Y; Nambot S; Haquet E; Vuadelle B; Genevieve D; Sarda P; Bruel AL; Kuentz P; Wells CF; Faivre L; Willems M
    Am J Med Genet A; 2018 Dec; 176(12):2813-2818. PubMed ID: 30365874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo deletion of TBL1XR1 in a child with non-specific developmental delay supports its implication in intellectual disability.
    Tabet AC; Leroy C; Dupont C; Serrano E; Hernandez K; Gallard J; Pouvreau N; Gadisseux JF; Benzacken B; Verloes A
    Am J Med Genet A; 2014 Sep; 164A(9):2335-7. PubMed ID: 24891185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heritable microduplication encompassing TBL1XR1 causes a genomic sister-disorder for the 3q26.32 microdeletion syndrome.
    Riehmer V; Erger F; Herkenrath P; Seland S; Jackels M; Wiater A; Heller R; Beck BB; Netzer C
    Am J Med Genet A; 2017 Aug; 173(8):2132-2138. PubMed ID: 28574232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Partial Deletion of the TBL1XR1 Gene Detected Using SNP Array in a Patient with Motor Delay, Growth Failure, and Klinefelter Syndrome.
    García-Payá E; Sirera Sirera P; Huertas-García I; Hernández Romero SD; Olivas García J
    Cytogenet Genome Res; 2023; 163(5-6):295-300. PubMed ID: 37844553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pierpont syndrome due to mutation c.1337A>G in TBL1XR1 gene.
    Tesarova M; Baxova A; Hansikova H; Lambert L; Vondrackova A; Leiska A; Zeman J
    Clin Dysmorphol; 2022 Jul; 31(3):145-148. PubMed ID: 35165208
    [No Abstract]   [Full Text] [Related]  

  • 10. A new syndrome of intellectual disability with dysmorphism due to TBL1XR1 deletion.
    Pons L; Cordier MP; Labalme A; Till M; Louvrier C; Schluth-Bolard C; Lesca G; Edery P; Sanlaville D
    Am J Med Genet A; 2015 Jan; 167A(1):164-8. PubMed ID: 25425123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased homozygosity in the first Hispanic patient with plantar lipomatosis, unusual facies, and developmental delay (Pierpont syndrome): a case report.
    O'Keefe S; Wefuan DT; Humberson JB; Schmidt K; Wiley J
    J Med Case Rep; 2016 Aug; 10(1):223. PubMed ID: 27520388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the genotypic and phenotypic spectrum associated with TBL1XR1 de novo variants.
    Ren M; Zheng H; Lu X; Lian W; Feng B
    Gene; 2023 Nov; 886():147777. PubMed ID: 37683765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An animal model for Pierpont syndrome: a mouse bearing the Tbl1xr1Y446C/Y446C mutation.
    Hu Y; Lauffer P; Stewart M; Codner G; Mayerl S; Heuer H; Ng L; Forrest D; van Trotsenburg P; Jongejan A; Fliers E; Hennekam R; Boelen A
    Hum Mol Genet; 2022 Aug; 31(17):2951-2963. PubMed ID: 35416977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of neurological presentation in individuals affected by TBL1XR1 gene defects.
    Nagy A; Molay F; Hargadon S; Brito Pires C; Grant N; De La Rosa Abreu L; Chen JY; D'Souza P; Macnamara E; Tifft C; Becker C; Melo De Gusmao C; Khurana V; Neumeyer AM; Eichler FS
    Orphanet J Rare Dis; 2024 Feb; 19(1):79. PubMed ID: 38378692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Arthrogryposis Multiplex Congenita Presentation in a Newborn With Pierpont Syndrome.
    Pereira-Nunes J; Vilan A; Grangeia A; d'Oliveira R
    J Investig Med High Impact Case Rep; 2023; 11():23247096221150637. PubMed ID: 36691917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pierpont syndrome: report of a new patient.
    Kahlert AK; Weidensee S; Mackenroth L; Porrmann J; Rump A; Di Donato N; Schröck E; Tzschach A
    Clin Dysmorphol; 2017 Oct; 26(4):205-208. PubMed ID: 28562391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing.
    Strom SP; Lozano R; Lee H; Dorrani N; Mann J; O'Lague PF; Mans N; Deignan JL; Vilain E; Nelson SF; Grody WW; Quintero-Rivera F
    BMC Med Genet; 2014 May; 15():49. PubMed ID: 24886118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plantar lipomatosis, unusual facies, and developmental delay: confirmation of Pierpont syndrome.
    Oudesluijs GG; Hordijk R; Boon M; Sijens PE; Hennekam RC
    Am J Med Genet A; 2005 Aug; 137(1):77-80. PubMed ID: 16007632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.